SEC Form 4 · accession 0000914190-15-000322
Cardiovascular Systems Inc · CSII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Martin
Officer — President and CEO · Director
Period of report
Aug 10, 2015
Accepted (ET)
Aug 12, 2015 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180145
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 10, 2015 | A | 56,036 | $0.00 | A | 423,454 | D | |
| Common StockF2 | Aug 10, 2015 | A | 56,036 | $0.00 | A | 479,490 | D | |
| Common StockF3 | Aug 10, 2015 | A | 37,358 | $0.00 | A | 516,848 | D | |
| Common Stock | holding | — | — | — | 850 | I | By child | |
| Common Stock | holding | — | — | — | 350 | I | By child | |
| Common Stock | holding | — | — | — | 850 | I | By child |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $7.90 | holding | — | — | — | — | Jun 11, 2017 | Common Stock | 90,580 | 90,580 | D |
| Stock Option (right to buy)F4 | $12.15 | holding | — | — | — | — | Dec 11, 2017 | Common Stock | 234,395 | 234,395 | D |
| Stock Option (right to buy)F4 | $8.75 | holding | — | — | — | — | Mar 1, 2019 | Common Stock | 32,350 | 32,350 | D |
Explanation of responses
- F1Subject to performance-based forfeiture based on total shareholder return for fiscal 2016 versus the Company's peer group.
- F2Subject to performance-based forfeiture based on annual revenue growth for fiscal 2016 versus the Company's peer group.
- F3Restrictions lapse as to 12,453 shares on 8/13/16 and 8/13/17 and 12,452 shares on 8/13/18.
- F4Fully exercisable.